The Effect of IBD Flares on Serum PSA
The Effect of Inflammatory Bowel Disease Flares on Serum Prostate Specific Antigen
Northwestern University
400 participants
Aug 1, 2019
OBSERVATIONAL
Conditions
Summary
This study will measure Prostate Specific Antigen (PSA) values in men with Inflammatory Bowel Disease (IBD) before, during, and following a flare. In addition, the effect of any PSA increase will be analyzed and correlated to the location of disease (rectal vs. other). Study findings may help men with IBD by identifying pitfalls in prostate cancer screening for this population and help to stratify and understand the effect IBD has on the prostatic milieu. By optimizing how men with IBD are screened for prostate cancer, future unnecessary healthcare encounters and expenditures may be reduced for this patient group.
Eligibility
Inclusion Criteria2
- Men, ages 40-69 years old
- Confirmed diagnosis of IBD presenting to the Northwestern Memorial Hospital Gastroenterology Clinic
Exclusion Criteria1
- History of prostate cancer or prior prostate procedures (biopsies or transurethral resection)
Interventions
Subjects will have their blood drawn during clinic visits over the course of the study period to measure their serum prostate specific antigen levels.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03558048